ME01484B - Kinolinski derivati kao antibakterijski agensi - Google Patents
Kinolinski derivati kao antibakterijski agensiInfo
- Publication number
- ME01484B ME01484B MEP-2012-127A MEP12712A ME01484B ME 01484 B ME01484 B ME 01484B ME P12712 A MEP12712 A ME P12712A ME 01484 B ME01484 B ME 01484B
- Authority
- ME
- Montenegro
- Prior art keywords
- alkyl
- alkyloxy
- hydrogen
- het
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Ovaj pronalazak se odnosi na upotrebu jedinjenja za proizvodnju leka za tretman bakterijske infekcije, pri čemu je pomenuto jedinjenje predstavljeno sa formulom (Ia) ili (lb) ili njegova farmaceutski prihvatljiva kisela ili bazna adiciona so, njegova stereohemijska izomerna forma, njegova tautomertna forma ili njegov A-oksid, gde R 1 je vodonik, halo, haloalkil, cijano, hidroksi, Ar, Het, alkil, alkiloksi, alkiltio, alkiloksialkil, alkiltioalkil, Ar-alkil ili di(Ar)alkil; p je c eli broj jednak 1, 2, 3 ili 4; R 2 je vodonik, hidroksi, merkapto, alkiloksi, alkiloksi alkiloksi, alkiltio, mono ili di(alkil)amino ili radikal sa formulom gde Y je CH 2 , O, S, NH ili A-alkil; R 3 je alkil, Ar, Ar-alkil, Het ili Het-alkil; Q je c eli broj jednak 1, 2 ili 3; R 4 i R 5 svaki nezavisno su vodonik, alkil ili benzil; ili R 4 i R 5 zajedno i uključujući N na kojeg su spojeni, mogu da formiraju radikal koji je izabran iz grupe koja obuhvata pirolidinil, 2-pirolinil, 3-pirolinil, pirolil, imidazolidinil, pirazolidinil, 2-imidazolinil, 2-pirazolinil, imidazolil, pirazolil, triazolil, piperidinil, piridinil, piperazinil, piridazinil, pirimidinil, piraziniI, triazin il, morfolinil i tiomorfolinil, koji je ponekad supstituisan sa alkilom, halo, haloalkilom, hidroksi, alkiloksi, ainino, mono- ili dialkilamino, alkiltio, alkiloksialkilom, alkiltioalkilom ili pirimidinilom; R 6 je vodonik, halo, haloalkil, hidroksi, Ar, al kil, alkiloksi, alkiltio, alkiloksialkil, alkiltioalkil, Ar-alkil ili di(Ar)alkil; ili dva susedna R 6 radikala mogu da zajedno formiraju bivalentan radikal sa formulom -CH=CH-CH=CH-; R je c eli broj jednak 1, 2, 3, 4 ili 5; R 7 je vodonik, alkil, Ar ili Het; R 8 je vodonik ili alkil; R 9 je okso; ili R 8 i R 9 zajedno formiraju radikal -CH=CH-N=.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05105762 | 2005-06-28 | ||
| PCT/EP2006/063553 WO2007000435A1 (en) | 2005-06-28 | 2006-06-26 | Quinoline derivatives as antibacterial agents |
| EP06763889A EP1898914B1 (en) | 2005-06-28 | 2006-06-26 | Quinoline derivatives as antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME01484B true ME01484B (me) | 2014-04-20 |
Family
ID=34940244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2012-127A ME01484B (me) | 2005-06-28 | 2006-06-26 | Kinolinski derivati kao antibakterijski agensi |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US8841321B2 (me) |
| EP (1) | EP1898914B1 (me) |
| JP (1) | JP5193858B2 (me) |
| KR (1) | KR101329585B1 (me) |
| CN (1) | CN101247811B (me) |
| AP (1) | AP2386A (me) |
| AR (1) | AR054626A1 (me) |
| AU (1) | AU2006263883B2 (me) |
| BR (1) | BRPI0612498A8 (me) |
| CA (1) | CA2612619C (me) |
| CY (1) | CY1113579T1 (me) |
| DK (1) | DK1898914T3 (me) |
| EA (1) | EA014423B1 (me) |
| ES (1) | ES2393203T3 (me) |
| HK (1) | HK1122730A1 (me) |
| HR (1) | HRP20120912T1 (me) |
| IL (1) | IL188393A0 (me) |
| JO (1) | JO2752B1 (me) |
| ME (1) | ME01484B (me) |
| MX (1) | MX2008000081A (me) |
| MY (1) | MY153291A (me) |
| NO (1) | NO342701B1 (me) |
| NZ (1) | NZ564379A (me) |
| PA (1) | PA8683801A1 (me) |
| PL (1) | PL1898914T3 (me) |
| PT (1) | PT1898914E (me) |
| RS (1) | RS52517B (me) |
| SI (1) | SI1898914T1 (me) |
| TW (1) | TWI387457B (me) |
| UA (1) | UA92175C2 (me) |
| WO (1) | WO2007000435A1 (me) |
| ZA (1) | ZA200711165B (me) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2970B1 (en) | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| US9617244B2 (en) | 2012-04-27 | 2017-04-11 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| AU2013254674B2 (en) | 2012-04-27 | 2017-02-02 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| PT3237383T (pt) | 2014-12-23 | 2020-01-15 | Albemarle Corp | Processo num passo para a síntese de análogos de metirapona alquilados |
| CN106928139B (zh) * | 2017-05-08 | 2019-06-25 | 福建省微生物研究所 | 一种贝达喹啉杂质的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19937116A1 (de) * | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
| NZ538391A (en) * | 2002-07-25 | 2005-10-28 | Janssen Pharmaceutica Nv | Quinoline derivatives and their use as mycobacterial inhibitors |
| AU2004278320B2 (en) * | 2003-09-22 | 2010-06-24 | Janssen Pharmaceutica, N.V. | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| BRPI0510414B1 (pt) * | 2004-05-28 | 2022-04-05 | Janssen Pharmaceutica N.V. | Combinação e composição farmacêutica |
| EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
| MX2008000079A (es) | 2005-06-28 | 2008-03-19 | Janssen Pharmaceutica Nv | Derivados de quinolina como agentes antibacterianos. |
-
2006
- 2006-06-25 JO JO2006188A patent/JO2752B1/en active
- 2006-06-26 US US11/993,145 patent/US8841321B2/en not_active Expired - Fee Related
- 2006-06-26 MX MX2008000081A patent/MX2008000081A/es active IP Right Grant
- 2006-06-26 KR KR1020087002107A patent/KR101329585B1/ko active IP Right Grant
- 2006-06-26 UA UAA200714927A patent/UA92175C2/ru unknown
- 2006-06-26 EP EP06763889A patent/EP1898914B1/en active Active
- 2006-06-26 WO PCT/EP2006/063553 patent/WO2007000435A1/en active Application Filing
- 2006-06-26 AU AU2006263883A patent/AU2006263883B2/en not_active Ceased
- 2006-06-26 EA EA200800154A patent/EA014423B1/ru unknown
- 2006-06-26 NZ NZ564379A patent/NZ564379A/en not_active IP Right Cessation
- 2006-06-26 DK DK06763889.0T patent/DK1898914T3/da active
- 2006-06-26 SI SI200631468T patent/SI1898914T1/sl unknown
- 2006-06-26 JP JP2008518810A patent/JP5193858B2/ja not_active Expired - Fee Related
- 2006-06-26 BR BRPI0612498A patent/BRPI0612498A8/pt not_active Application Discontinuation
- 2006-06-26 PT PT06763889T patent/PT1898914E/pt unknown
- 2006-06-26 CA CA2612619A patent/CA2612619C/en not_active Expired - Fee Related
- 2006-06-26 CN CN2006800310552A patent/CN101247811B/zh not_active Expired - Fee Related
- 2006-06-26 ME MEP-2012-127A patent/ME01484B/me unknown
- 2006-06-26 AP AP2008004303A patent/AP2386A/xx active
- 2006-06-26 RS RS20120480A patent/RS52517B/en unknown
- 2006-06-26 ES ES06763889T patent/ES2393203T3/es active Active
- 2006-06-26 PL PL06763889T patent/PL1898914T3/pl unknown
- 2006-06-27 TW TW095123127A patent/TWI387457B/zh not_active IP Right Cessation
- 2006-06-27 MY MYPI20063044A patent/MY153291A/en unknown
- 2006-06-28 PA PA20068683801A patent/PA8683801A1/es unknown
- 2006-06-28 AR ARP060102787A patent/AR054626A1/es unknown
-
2007
- 2007-12-20 ZA ZA2007/11165A patent/ZA200711165B/en unknown
- 2007-12-25 IL IL188393A patent/IL188393A0/en active IP Right Grant
-
2008
- 2008-01-28 NO NO20080501A patent/NO342701B1/no not_active IP Right Cessation
- 2008-12-24 HK HK08113967.4A patent/HK1122730A1/xx not_active IP Right Cessation
-
2012
- 2012-11-13 HR HRP20120912TT patent/HRP20120912T1/hr unknown
- 2012-11-14 CY CY20121101090T patent/CY1113579T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080064L (no) | Kinolinderivater som antibakterielle midler | |
| ME01484B (me) | Kinolinski derivati kao antibakterijski agensi | |
| RS51730B (en) | HINOLINE DERIVATIVES FOR TREATMENT OF LATENT TUBERCULOSIS | |
| ZA200707009B (en) | Multimers of pyrimidinone derivatives and their use as human neutrophil elastate inhibitors | |
| RS53065B (en) | QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS | |
| BRPI0810641A2 (pt) | "compostos farmacêuticos". | |
| HRP20090208T1 (en) | Substituted pyrido(2,3-d)pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders | |
| NZ592925A (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
| NO20090580L (no) | Syklopenta[D]pyrimidiner som AKT-proteinkinaseinhibitorer | |
| NO20081026L (no) | Kinolinderivater som antibakterielle midler | |
| CY1113535T1 (el) | Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες | |
| NO20080481L (no) | Kinolinderivater som antibakterielle midler | |
| TW200637556A (en) | Substituted 5-phenyl pyrimidines I in therapy | |
| DE602007010038D1 (de) | Pyrimidylderivate als proteinkinaseinhibitoren | |
| EA200500802A1 (ru) | Лечение латентного туберкулёза | |
| EA200500800A1 (ru) | Производные хинолина в качестве антибактериальных агентов | |
| UA91181C2 (ru) | Хинолина производные как антибактериальные агенты | |
| TW200716109A (en) | Quinoline derivatives as antibacterial agents | |
| NZ621521A (en) | 1-oxo-isoquinolines and uses thereof |